2017. ID: 2036 Next-generation sequencing to evaluate frequency of BCR-ABL1 kinase domain Imatinib-resistance mutations. Biomedical Research and Therapy. 4, S (Sep. 2017), S67. DOI:https://doi.org/10.15419/bmrat.v4iS.275.